Psychedelics as a Legal Cure for Mental Health: A Deep Dive

Psychedelics as a Legal Cure for Mental Health: A Deep Dive

Depression is a leading cause of disability, absenteeism, and presenteeism in the workplace. A healthier workforce, after all, is a more productive workforce—and a less expensive one. The CDC estimates that depression results in 200 million lost workdays each year, which costs employers $17 to $44 billion.

Traditional treatment for depression, like selective serotonin reuptake inhibitors (SSRIs), doesn’t serve everyone. Legal psychedelics, such as psilocybin (found in certain mushrooms), ketamine and MDMA, have shown promise in treating various mental health problems, particularly when administered in a controlled and therapeutic setting. They can speed up the process and create profound changes in overall mental health. Join us for a look into the research that explains what happens in the brain, how psychedelics work and why employers might want to consider adding these to their plan benefits.

Key Takeaways:

• Understand the history of psychedelics in the mental health field

• Learn how the chemicals heal and treat various mental illnesses

• Understand the treatment methods using these types of drugs

• Discover why adding these treatments can create a healthier workforce

For Health Action Council members only
SHRM, HRCI, and CEBS credit